[go: up one dir, main page]

EA003470B1 - Фармацевтическая композиция тгп и ингибитора апф - Google Patents

Фармацевтическая композиция тгп и ингибитора апф Download PDF

Info

Publication number
EA003470B1
EA003470B1 EA200100477A EA200100477A EA003470B1 EA 003470 B1 EA003470 B1 EA 003470B1 EA 200100477 A EA200100477 A EA 200100477A EA 200100477 A EA200100477 A EA 200100477A EA 003470 B1 EA003470 B1 EA 003470B1
Authority
EA
Eurasian Patent Office
Prior art keywords
enalapril
animals
pharmaceutical composition
heart
treatment
Prior art date
Application number
EA200100477A
Other languages
English (en)
Russian (ru)
Other versions
EA200100477A1 (ru
Inventor
Иварс Калвиньш
Марис Веверис
Юрис Бундулис
Илзе Скарда
Original Assignee
Иварс Калвиньш
Марис Веверис
Юрис Бундулис
Илзе Скарда
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иварс Калвиньш, Марис Веверис, Юрис Бундулис, Илзе Скарда filed Critical Иварс Калвиньш
Publication of EA200100477A1 publication Critical patent/EA200100477A1/ru
Publication of EA003470B1 publication Critical patent/EA003470B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200100477A 1998-10-29 1999-10-27 Фармацевтическая композиция тгп и ингибитора апф EA003470B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LVP-98-252A LV12491B (lv) 1998-10-29 1998-10-29 Farmaceitiska kompozīcija
PCT/LV1999/000005 WO2000025773A1 (en) 1998-10-29 1999-10-27 Pharmaceutical combination of mildronate and enalapril

Publications (2)

Publication Number Publication Date
EA200100477A1 EA200100477A1 (ru) 2001-10-22
EA003470B1 true EA003470B1 (ru) 2003-06-26

Family

ID=19736545

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100477A EA003470B1 (ru) 1998-10-29 1999-10-27 Фармацевтическая композиция тгп и ингибитора апф

Country Status (5)

Country Link
EP (1) EP1124547A1 (lv)
EA (1) EA003470B1 (lv)
LV (1) LV12491B (lv)
UA (1) UA71934C2 (lv)
WO (1) WO2000025773A1 (lv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2467748C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее эндотелиопротекторной активностью

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof
EP2420224A1 (en) * 2010-08-11 2012-02-22 Grindeks, a joint stock company Method for producing a stable 3-(2,2,2-trimethylhydrazinium)propionate dihydrate solid pharmaceutical composition
CN105853349A (zh) * 2016-04-29 2016-08-17 济南康和医药科技有限公司 一种米屈肼注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2467748C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее эндотелиопротекторной активностью

Also Published As

Publication number Publication date
EP1124547A1 (en) 2001-08-22
EA200100477A1 (ru) 2001-10-22
UA71934C2 (en) 2005-01-17
LV12491A (en) 2000-06-20
LV12491B (lv) 2000-12-20
WO2000025773A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
EP1162980B1 (en) Pyridoxine compounds in the treatment of cardiovascular pathologies
JPS60188323A (ja) 心筋虚血治療用医薬組成物
PT1437131E (pt) Utilização de ramipril para a prevenção de diabetes num doente sem insuficiência cardíaca congestiva pré-existente
Ulvenstam et al. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study
HU226022B1 (en) Process for preparation pharmaceutical composition combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
KR0148645B1 (ko) 심장 보호제
BG99164A (bg) Антиисхемично лекарствено средство
CA2013801A1 (en) Synergistic compositions containing ketanserin
CN1181019A (zh) 含有贝那普利或贝那普利拉和维沙坦的药物组合物
HU206186B (en) Process for producing pharmaceutical compositions comprising amino acid derivatives having ace-inhibiting effect
EP0425956A2 (en) ACE inhibitors for use for stabilizing or causing regression of atherosclerosis in coronary arteries
Matsuo et al. Effects of an angiotensin II antagonist on reperfusion arrhythmias in dogs
US8088799B2 (en) Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
EA003470B1 (ru) Фармацевтическая композиция тгп и ингибитора апф
KR100623166B1 (ko) 심부전 치료를 위한 코르티졸 길항제의 용도
CA2870373A1 (en) Lercanidipine hydrochloride and losartan potassium compound preparation and preparation method thereof
JP2957618B2 (ja) アミオダロンと、ニトロ誘導体、特にイソソルビト二硝酸と、必要に応じてさらにβ―遮断薬とを含む心臓保護効果のある医薬組成物
Materson Monotherapy of hypertension with angiotensin-converting enzyme inhibitors
RU2261097C2 (ru) Применение моксонидина для лечения постинфарктных состояний
SK285428B6 (sk) Použitie (-)-[[4-(1,4,5,6-tetrahydro-4-metyl-6-oxo-3- pyridazinyl)fenyl]hydrazono]propándinitrilu na výrobu lieku na liečbu vazospazmu koronárneho štepu
EP0527720B1 (en) Therapeutic agents
FR2586352A1 (fr) Compositions pharmaceutiques contenant une coenzyme du type ubiquinone, douees d'activite de protection cardiaque et metabolique sur le metabolisme energetique musculaire
JPH10139664A (ja) 抗不整脈薬
GB2241890A (en) Preventing onset of or treating protein catabolism using an ace inhibitor
JPH08165239A (ja) 抗動脈硬化剤

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY KZ RU